Active Ingredient(s):Nalmefene FDA Approved: * April 17, 1995 Pharm Company: *BAXTER HLTHCARE CORP Category:Alcoholism
Nalmefene, sold under the brand name Selincro, is an opioid antagonist used primarily in the management of alcohol dependence. It has also been investigated for the treatment of other addictions such as pathological gambling. It is taken by mouth.
Nalmefene is an opiate derivative similar in both structure and activity to the opioid antagonist naltrexone. Advantages of nalmefene relative to naltrexone include a longer elimination half-life, greater oral bioavailability, and...
* May have multiple approval dates, manufacturers, or labelers.